Baseline and On‐Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene‐Addicted Adenocarcinoma of the Lung
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Thoracic Oncology"
DOI: 10.1016/j.jtho.2017.08.005
Abstract: Introduction The role of serum tumor markers in the modern management of advanced NSCLC remains poorly described. Methods A single‐center retrospective analysis of available carcinoembryonic antigen, CA125, CA19.9, and CA27.29 levels at baseline and during… read more here.
Keywords: tumor markers; baseline treatment; lung; serum tumor ... See more keywords
0748 A Novel, Non-Pharmacological Treatment Option for Patients With Idiopathic Hypersomnia
Sign Up to like & getrecommendations! Published in 2020 at "Sleep"
DOI: 10.1093/sleep/zsaa056.744
Abstract: There is some evidence suggesting that patients with hypersomnia have delayed circadian timing, which could explain, at least in part, the excessive sleepiness and impaired daytime performance experienced by these individuals. This study investigated the… read more here.
Keywords: baseline treatment; treatment; idiopathic hypersomnia; pharmacological treatment ... See more keywords
Decrease in tumor content assessed in biopsies is associated with improved treatment outcome response to pembrolizumab in patients with rare tumors
Sign Up to like & getrecommendations! Published in 2020 at "Journal for Immunotherapy of Cancer"
DOI: 10.1136/jitc-2020-000665
Abstract: Background Decreased tumor content (TC) in resection specimens after neoadjuvant therapy is used to predict prognosis. We investigated whether TC assessed in biopsy specimens or the shift in TC from baseline to on-treatment can be… read more here.
Keywords: baseline treatment; response; treatment; patients rare ... See more keywords